ADA-SCID

6 clinical trials · Condition

Record	Firm	Date
EZN-2279 in Patients With ADA-SCID (NCT01420627)	Leadiant Biosciences, Inc.	2014-01-24
Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector (NCT02022696)	National Human Genome Research Institute (NHGRI)	2013-12-16
Autologous CD34+ Hematopoietic Stem Cells Transduced ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for the Human ADA Gene (NCT01852071)	University of California, Los Angeles	2013-08-02
Patients Treated for SCID (1968-Present) (NCT01346150)	National Institute of Allergy and Infectious Diseases (NIAID)	2011-05-15
Natural History Study of SCID Disorders (NCT01186913)	National Institute of Allergy and Infectious Diseases (NIAID)	2010-09-02
Quality of Life and Neuropsychiatric Sequelae in Patients Treated With Gene Therapy for ADA-SCID and in Their Parents (NCT01182857)	National Human Genome Research Institute (NHGRI)	2010-08-05

Every clearance here is in the API, with alerts when new ones post.